Early stage investors in Basel-Stadt, Switzerland
Updated 16 Nov 2026
Venture funds
1 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Novartis Venture Fund Novartis Venture Fund focuses on novel therapeutics and platforms, with recent investments in Hepalink and FoRx Therapeutics. Basel, Switzerland |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 27% | 2 |
Table 1. Early stage investors in Basel-Stadt, Switzerland: venture capital and micro VC funds ranked by companies whose Series A and B round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | •••@sosei.com | 877 28••• |
| Roche Venture Fund | Corporate venture arm | Basel, Switzerland | •••@roche.com | |
| BioMedPartners | Venture capital firm | Basel, Switzerland | •••@biomedvc.com | +41 61••• |
| Syngenta Ventures | Venture capital firm | Basel, Switzerland | •••@mriseed.com | 800-26••• |
| Kickfund | Venture capital firm | Basel, Switzerland | •••@kickfund.ch | |
| Infinitas Capital | Family office | Basel, Switzerland | •••@infinitas-capital.com | +41 06••• |
| MTIP AG | Private equity firm | Basel, Switzerland | •••@mtip.ch | +41615••• |
| Gebert Rüf Stiftung | Entrepreneurship program | Basel, Switzerland | •••@grstiftung.ch | +41061••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 11 of the 20 early stage investors in Basel-Stadt, Switzerland have a published email address, 12 a phone number and 17 a website.
- Novartis Venture Fund has the most recorded investments, 279, 75 of them as lead investor.
- 3 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Novartis Venture Fund is an investor in 2 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Cour Pharmaceuticals Development's $50.0M Series B on 18 June 2026.
- Health care is the most common sector across their 63 portfolio companies (65%).
- Seed is the most common investment stage, recorded for 12 of them (60%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Early stage investors in Basel-Stadt, Switzerland
17 of 20, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Novartis Venture Fund | Corporate venture arm, Venture capital firm | Basel, Switzerland | Health care, Biotech | Hepalink, FoRx Therapeutics | 2 | 279 | 75 | 77 | •••@sosei.com | 877 28••• | |
| 2 | Roche Venture Fund | Corporate venture arm | Basel, Switzerland | Health care, Biotech | Cour Pharmaceuticals Development | 1 | 121 | 15 | 41 | •••@roche.com | In the CSV | |
| 3 | BioMedPartners | Venture capital firm | Basel, Switzerland | Biotech, Health care | TOLREMO therapeutics, Topas Therapeutics, Amal Therapeutics | 87 | 29 | 22 | •••@biomedvc.com | +41 61••• | In the CSV | |
| 4 | Syngenta Ventures | Venture capital firm | Basel, Switzerland | Fintech, Biotech | WeedOut, Tarfin, Agworld | 54 | 9 | 7 | •••@mriseed.com | 800-26••• | ||
| 5 | DayOne accelerator | Startup accelerator, Startup incubator | Basel, Switzerland | 53 | 53 | 1 | In the CSV | |||||
| 6 | Kickfund | Venture capital firm | Basel, Switzerland | Health care, Biotech | a-metal, Adiposs, NXI Therapeutics | 49 | 8 | 1 | •••@kickfund.ch | In the CSV | ||
| 7 | dRx Capital | Corporate venture arm, Venture capital firm | Basel, Switzerland | Biotech, Health care | Dopavision | 31 | 4 | 8 | In the CSV | |||
| 8 | Helvetia Venture Fund | Venture capital firm | Basel, Switzerland | Fintech, Health care | FAAREN Group GmbH, INKI.TECH, Urban Connect | 30 | 16 | 3 | +41058••• | In the CSV | ||
| 9 | Infinitas Capital | Family office, Venture capital firm | Basel, Switzerland | Education, Hardware | einwert, Storypod, Olsam Group | 26 | 4 | 4 | •••@infinitas-capital.com | +41 06••• | In the CSV | |
| 10 | MTIP AG | Private equity firm | Basel, Switzerland | Health care, Artificial intelligence | NitiNotes, Hexarad, Apricity | 22 | 13 | 4 | •••@mtip.ch | +41615••• | In the CSV | |
| 11 | Gebert Rüf Stiftung | Entrepreneurship program, Government investment office | Basel, Switzerland | Biotech, Health care | NXI Therapeutics, Hemotune, POLYNEURON | 22 | 11 | 0 | •••@grstiftung.ch | +41061••• | In the CSV | |
| 12 | AVANTECA Partners | Private equity firm | Basel, Switzerland | 7 | 2 | 0 | In the CSV | |||||
| 13 | EVA Basel | Entrepreneurship program, Venture capital firm | Basel, Switzerland | Health care, Biotech | Inthera Bioscience, AOT - Advanced Osteotomy Tools | 6 | 3 | 2 | •••@eva-basel.ch | +41612••• | In the CSV | |
| 14 | New Energies Invest | Venture capital firm | Basel, Switzerland | 3 | 1 | 2 | •••@newenergies.ch | +41 61••• | ||||
| 15 | CPV / CAP Pension Fund Coop. | Pension fund | Basel, Switzerland | 2 | 1 | 0 | +41 61••• | In the CSV | ||||
| 16 | Erfindungs Verwertung | Venture capital firm | Basel, Switzerland | 1 | 0 | 0 | +41 61••• | In the CSV | ||||
| 17 | Around Capital | Family office, Startup incubator | Basel, Switzerland | 0 | 0 | 0 | •••@aroundcapital.com | In the CSV |
Table 2. Early stage investors in Basel-Stadt, Switzerland: the first 17 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 20.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Novartis Venture Fund | Basel, Switzerland | 2 | 20 | Hepalink, FoRx Therapeutics |
| 2 | Roche Venture Fund | Basel, Switzerland | 1 | 3 | Cour Pharmaceuticals Development |
| 3 | Wecken & Cie. | Basel, Switzerland | 1 | 6 | happyhotel |
Table 3. Early stage investors in Basel-Stadt, Switzerland: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Cour Pharmaceuticals Development | Cour Pharmaceuticals Development develops nanoparticle technology to reset immune systems in multiple sclerosis patients. | Biotech | Skokie, United States | Series B | $50.0M | 2026-06-18 | $185.5M | Roche Venture Fund | 51 to 100 | 2015 |
| happyhotel | happyhotel offers an AI sales manager that automates the sales process for hotels. | Artificial intelligence | Offenburg, Germany | Series A | $7.7M | 2026-02-19 | $7.7M | Wecken & Cie. | 11 to 50 | 2019 |
| FoRx Therapeutics | FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. | Biotech | Basel, Switzerland | Series A | $50.0M | 2025-12-18 | $109.4M | Novartis Venture Fund | 11 to 50 | 2019 |
Table 4. Early stage investors in Basel-Stadt, Switzerland: the 3 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Health care | 41 | 65% |
| Biotech | 34 | 54% |
| Software | 19 | 30% |
| Artificial intelligence | 6 | 10% |
| Hardware | 4 | 6% |
| Fintech | 3 | 5% |
| Commerce | 2 | 3% |
| Education | 1 | 2% |
Table 5. Early stage investors in Basel-Stadt, Switzerland: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 20 | 100% |
| Seed investors | 12 | 60% |
| Late stage investors | 9 | 45% |
| Venture investors | 7 | 35% |
| Post IPO investors | 2 | 10% |
| Convertible note investors | 2 | 10% |
| Private equity investors | 2 | 10% |
| Grant makers | 1 | 5% |
Table 6. Early stage investors in Basel-Stadt, Switzerland by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 2 | 12% |
| 2010s | 5 | 29% |
| 2000s | 4 | 24% |
| 1990s | 4 | 24% |
| 1900s | 1 | 6% |
| 1850s | 1 | 6% |
Table 7. Early stage investors in Basel-Stadt, Switzerland by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include early stage investors and its headquarters is in Basel-Stadt, Switzerland. On 16 November 2026 that is 20 investors.
- 11 rows carry an email address and 12 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 17 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 20 rows: 3 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many early stage investors in Basel-Stadt, Switzerland are on the list?
- 20, in the file dated 16 November 2026. 3 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 11 of the 20 carry an email address in the download and 12 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 20 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 20 rows, 11 firm email addresses and 12 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 8 of the 11 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.